VARANESE, SARA
 Distribuzione geografica
Continente #
EU - Europa 990
NA - Nord America 873
AS - Asia 408
SA - Sud America 3
OC - Oceania 2
Totale 2.276
Nazione #
US - Stati Uniti d'America 871
CN - Cina 212
IT - Italia 206
UA - Ucraina 181
IE - Irlanda 155
GB - Regno Unito 114
TR - Turchia 98
FR - Francia 95
SE - Svezia 95
DE - Germania 76
SG - Singapore 54
IN - India 40
FI - Finlandia 37
RU - Federazione Russa 21
CH - Svizzera 5
BR - Brasile 3
IR - Iran 3
NL - Olanda 2
NZ - Nuova Zelanda 2
CA - Canada 1
CZ - Repubblica Ceca 1
MX - Messico 1
RO - Romania 1
SI - Slovenia 1
VN - Vietnam 1
Totale 2.276
Città #
Jacksonville 218
Chandler 200
Dublin 154
Southend 107
Princeton 83
Nanjing 65
Izmir 63
Singapore 40
Cambridge 35
Wilmington 32
Nanchang 30
Beijing 23
Dearborn 22
Ashburn 19
Altamura 18
Grevenbroich 15
Rome 15
Milan 14
Shenyang 13
Boardman 9
Hebei 9
Kunming 9
Ann Arbor 8
Taizhou 8
Augusta 7
Changsha 7
Genova 6
Jiaxing 6
Jinan 6
Leawood 6
Los Angeles 6
Norwalk 6
Monmouth Junction 5
Tianjin 5
Changchun 4
Chiasso 4
Falls Church 4
Lanzhou 4
Ningbo 4
Santa Clara 4
Shanghai 4
Appiano Gentile 3
Boretto 3
Caserta 3
Catania 3
Guangzhou 3
London 3
Nova Iguaçu 3
Sammichele di Bari 3
San Mateo 3
Washington 3
Zhengzhou 3
Aosta 2
Ardabil 2
Arezzo 2
Campobasso 2
Cesano Maderno 2
Clifton 2
Florence 2
Hangzhou 2
Helsinki 2
Houston 2
Mistretta 2
Mumbai 2
Napoli 2
New York 2
Nürnberg 2
Orange 2
Poggio Picenze 2
Porto Torres 2
Rovereto 2
Spoltore 2
Torino 2
Villanova Del Ghebbo 2
Alessandria 1
Andover 1
Antea 1
Auckland 1
Bangalore 1
Bari 1
Bologna 1
Candia Lomellina 1
Capua 1
Casoria 1
Casteldaccia 1
Chennai 1
Christchurch 1
Cornaredo 1
Dallas 1
Dolo 1
Edinburgh 1
Giugliano in Campania 1
Giulianova 1
Guardiagrele 1
Haikou 1
Hanoi 1
Hefei 1
Jesi 1
Jinhua 1
Latina 1
Totale 1.400
Nome #
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 217
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 79
Bipallidal lesions induce delayed and progressive parkinsonism 74
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 71
Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: A comparison with other clinical executive tasks. 69
Irrelevant features of a stimulus can either facilitate or disrupt performance in a working memory task: The role of fluid intelligence. 69
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 69
PSI proteasome inhibitor induced rat model of Parkinson’s Disease. 68
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 68
Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. 67
Clinical and electrohysiological analysis of the fluctuating cognition in patients affected by Dementia with Lewy Bodies. 65
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease. 63
PSI induce proteasome inhibition and motor disturbances in rats 63
Acetyl-L-carnitine:from a biological curiosity to a drug for the peripheral nervous system and beyond. 63
Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy 63
Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease. 62
Attention modulation regulates both motor and non-motor performance: a high-density EEg study in parkinson's disease 61
Un caso di sindrome disesecutiva in una paziente sottoposta ad STN-DBS: follow-up da 0 a 10 mesi 61
Levetiracetam in patients with chronic epilepsy: the seizure outcome 59
EEG comparison in early AD, LBD, PDD patients with a 2-year follow-up 59
Cortical rhythms in ad, lbd and normal subjects: a quantitative MEG study 57
Camptocormia in Lewy body disease (LBD) in comparison with Parkinson's disease (PD) 57
Study of mitochondrial function in a psi-induced model of parkinson’s disease. 56
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies. 55
Camptocormia in Lewy Body Disease (LBD) in comparison with Parkinson’s Disease (PD). 55
Protracted benefit from paradoxical kinesia in typical and atypical parkinsonisms. 53
Electrophysiological indices of interference resolution covary with individual fluid intelligence:investigating reactive control processes in 3-back working memory task. 52
Catamenial end-off dose in Parkinson's disease 51
End –off dose catameniale nella malattia di Parkinson 48
Pathophysiology of Mental Disturbances in Parkinsonism 48
Incidence of RBD and hallucination in patients affected by Parkinson's disease 48
Pathophysiology of mental Disturbances in Parkinsonism 44
Hedonistic homeostatic dysregulation in Parkinson s Disease: Prevalence and incidence. Alzheimer’s and Parkinson’s disease: Insights, progress and perspectives 44
PSI produce l’inibizione del proteasoma causando disturbi motori in ratti 44
Botulinum toxin treatment of lateral axial dystonia in Parkinsonism 44
Pathophysiology of mental disturbances in parkinsonism 43
Modafinil and armodafinil improve attention and global mental status in Lewy bodies disorders: preliminary evidence 40
Totale 2.309
Categoria #
all - tutte 8.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020295 0 36 2 10 42 17 52 52 12 23 48 1
2020/2021242 39 5 39 2 8 44 6 7 26 33 31 2
2021/2022155 3 1 4 26 9 3 6 18 7 7 23 48
2022/2023544 45 72 40 40 52 109 34 35 85 6 9 17
2023/2024195 14 17 11 3 10 43 66 2 3 4 0 22
2024/202576 32 44 0 0 0 0 0 0 0 0 0 0
Totale 2.309